Insider Transactions in Q2 2025 at Metagenomi, Inc. (MGX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2025
|
Matthew Wein |
SELL
Open market or private sale
|
Direct |
199
-1.18%
|
$199
$1.75 P/Share
|
|
Jun 06
2025
|
Sarah B. Noonberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,239
-4.58%
|
$5,239
$1.75 P/Share
|
|
Jun 06
2025
|
Brian C. Thomas Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,785
-0.43%
|
$10,785
$1.75 P/Share
|
|
Jun 06
2025
|
Pamela Wapnick Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,576
-2.14%
|
$1,576
$1.75 P/Share
|
|
Jun 06
2025
|
Jian Irish |
SELL
Open market or private sale
|
Direct |
6,390
-1.98%
|
$6,390
$1.75 P/Share
|
|
Apr 01
2025
|
Sarah B. Noonberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+10.91%
|
-
|
|
Apr 01
2025
|
Matthew Wein |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+20.02%
|
-
|
|
Apr 01
2025
|
Jian Irish |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+6.67%
|
-
|
|
Apr 01
2025
|
Brian C. Thomas Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+1.25%
|
-
|
|
Apr 01
2025
|
Pamela Wapnick Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+15.97%
|
-
|